Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism cyp3a cyp450'

Search results for: 'research area metabolism cyp3a cyp450'

Items 1-10 of 11

Page
per page
  1. GW9662
    A4300 GW9662
     1 Citation
    Summary: PPARγ antagonist
      insoluble in H2O; ≥13.75 mg/mL
  2. T0070907
    A4301 T0070907
    Summary: Human PPARγ antagonist,potent and selective
      ≥27.8 mg/mL
  3. Ciprofibrate
    A4306 Ciprofibrate
    Summary: PPARα agonist
      insoluble in H2O; ≥10.85 mg/mL
  4. GW501516
    A4309 GW501516
     1 Citation
    Summary: PPARδ agonist,selective and potent
      insoluble in H2O; ≥18.05 mg/mL
  5. Rosiglitazone HCl
    A4310 Rosiglitazone HCl
    Summary: PPARγ agonist
      ≥39.4 mg/mL
  6. Pioglitazone HCl
    A4324 Pioglitazone HCl
    Summary: PPARγ agonist
      insoluble in H2O; ≥19.65 mg/mL
  7. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
      ≥23.7 mg/mL
  8. GSK3787
    A4303 GSK3787
    Summary: PPARβ/δ antagonist,novel and irreversible
      insoluble in H2O; ≥15.8 mg/mL
  9. Rosiglitazone
    A4304 Rosiglitazone
    Summary: Potent PPARγ agonist
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  10. GW0742
    A4307 GW0742
    Summary: PPARδ/β agonist,potent and selective
      ≥47.1 mg/mL

Items 1-10 of 11

Page
per page